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Abstract
The heavy chain of murine ferritin, an iron storage
molecule with ferroxidase activity, was developed as a
novel endogenous reporter for the detection of gene
expression by magnetic resonance imaging (MRI).
Expression of both enhanced green fluorescent pro-
tein (EGFP) and influenza hemagglutinin (HA)–tagged
ferritin were tightly coregulated by tetracycline (TET),
using a bidirectional expression vector. C6 cells stably
expressing a TET-EGFP-HA-ferritin construct enabled
the dynamic detection of TET-regulated gene expres-
sion by MRI, followed by independent validation using
fluorescence microscopy and histology. MR relaxation
rates were significantly elevated both in vitro and
in vivo on TET withdrawal, and were consistent with
induced expression of ferritin and increase in intra-
cellular iron content. Hence, overexpression of ferritin
was sufficient to trigger cellular response, augmenting
iron uptake to a degree detectable by MRI. Application
of this novel MR reporter gene that generates sig-
nificant contrast in the absence of exogenously
administered substrates opens new possibilities
for noninvasive molecular imaging of gene expression
by MRI.
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Introduction
Advances in molecular biology and cellular biochemistry
provide innovative approaches for developing new molecu-
lar imaging probes for magnetic resonance imaging (MRI),
to allow noninvasive dynamic mapping of multiple parame-
ters of biologic processes. Such probes can be devel-
oped for specific molecular targets using antibodies,
ligands [1–4], or ‘‘smart’’ probes activated by a target
enzyme such as b-galactosidase [5–7]. Reporter enzymes
were suggested also for magnetic resonance spectroscopy
(MRS), including creatine kinase [8] and thymidine kinase
[9]. Another option for MRI reporter is the transferrin recep-
tor, in which contrast is generated by inducing receptor-
mediated internalization of exogenously administered
transferrin coupled to paramagnetic particles [2]. Recently,
tyrosinase-catalyzed melanin synthesis was suggested as
a reporter, in which contrast was generated by exogenously
administered iron, which binds to the melanin [10,11]. How-
ever, overexpression of either tyrosinase or transferrin receptor
could elevate radical formation by Fenton reaction due to the
increase in free iron concentration [12].
Thus far, all the reporter genes developed for MRI rely on
exogenous administration of contrast material; therefore, deliv-
ery barriers and clearance must be considered. The aim of our
work was to develop a novel endogenous reporter for imaging
gene expression by MRI. Endogenous reporter proteins for
optical imaging such as GFP are widely used. However, sensi-
tivity as well as resolution for detection of fluorescent proteins
are significantly limited by the depth of penetration and scatter-
ing of light. MRI offers exquisite spatial resolution for deep
tissues; thus, an endogenous reporter of gene expression for
MRI would provide an important tool, complementing optical
imaging for deep tissue molecular imaging.
Here we would like to propose ferritin as an endogenous
reporter protein for MRI, which would directly change the MR
signal, in its expression site, in analogy to fluorescent proteins
in optical imaging, without the need to administer additional
contrast materials (Figure 1). Overexpression of ferritin is
expected to transiently lower intracellular iron concentration,
leading to physiological compensation augmenting iron uptake.
Excess intracellular iron would be safely sequestered within the
overexpressed ferritin, thus minimizing iron toxicity. Sensitivity
for detection by MR would be enhanced by two mechanisms,
including net iron uptake as well as changes in iron relaxivity,
due to redistribution of the existing intracellular iron within a
larger ferritin pool. HA tag as well as enhanced green fluores-
cent protein (EGFP) were added to allow independent valida-
tion of the MRI data by molecular analysis and fluorescence
microscopy (Figure 1). Ferritin is a ubiquitous and highly
conserved iron-binding protein. In vertebrates, the cytosolic
ferritin is a heteropolymer composed of variable proportions of
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H and L subunits [13]. Twenty-four ferritin subunits assemble
to form the apoferritin shell. Each apoferritin molecule of
450 kDa can sequester up to 4500 iron atoms, depending
on the tissue type and physiologic status of the cell. Cellular
models in which ferritin expression was modulated revealed
that the heavy (H) chain is the main regulator of ferritin
activity. The H subunit has ferroxidase activity that promotes
iron oxidation and incorporation [14]. In contrast, the L-chain
lacks detectable ferroxidase activity but facilitates the activity
of the H-chain by offering sites for iron nucleation and
mineralization, and by increasing the turnover at the ferroxi-
dase center [15]. Cells transfected with the mouse H-chain
ferritin responded by upregulation of transferrin receptor and
increased iron uptake [16].
Ferritin shortens both T1 and T2 relaxation times; thus,
MRI was used for in vivo quantification of ferritin-bound iron
in liver and brain nuclei in pathologies including b-thalasse-
mia and Alzheimer’s disease [17,18]. Several in vitro studies
were conducted to determine the transverse (T2) relaxation
of water as a function of iron load on ferritin [19,20]. These
studies showed that the contribution of iron atoms to relax-
ivity is exceptionally high at low iron loading. Based on these
findings, we postulated that changes in the expression of
apoferritin and redistribution of iron could alter MR contrast
even in the absence of changes in total iron content [19].
A cassette of multimodality reporter genes was construct-
ed so as to allow tight tetracycline (TET) regulation of expres-
sion of ferritin as well as EGFP (Figure 1). The proposed
reporter would permit the detection of TET-regulated gene
expression by MRI, as well as independent validation by
fluorescence microscopy and histology, in genetically identi-
cal cells or tumors. We show here that overexpression of
ferritin H-chain in C6 rat glioma cells under TET regulation
(C6-TET-EGFP-HA-ferritin) increased cellular iron content in
vitro and significantly increased MR relaxation rates, both in
vitro and in vivo, without altering tumor growth. These results
indicate the potential use of ferritin as a reporter for dynamic
detection of gene expression by noninvasive MRI.
Figure 1. TET-regulated expression of EGFP-HA-ferritin as a multimodality endogenous reporter of gene expression for MRI and optical imaging. C6-TET-EGFP-
ferritin was generated by the infection of C6 cells with viruses carrying the TET transactivator (tTA) under a constitutive promoter (pRev-tTA-OFF-IN vector). The
cells were then transfected to express TET-EGFP-HA-ferritin using a bidirectional vector (pBI-EGFP-HA-Ferr vector). Selected clones showed overexpression of
EGFP and HA-tagged ferritin, both of which were tightly suppressed by administration of TET (+Tet). In the absence of TET (Tet), overexpression of ferritin leads
to redistribution of intracellular ferritin iron and chelation of intracellular free iron, thereby generating MR contrast by increasing R1 and R2 relaxation rates. Iron
homeostasis is restored by the compensatory expression of transferrin receptor and increased iron uptake, providing further gain in MR contrast.
110 Ferritin as an Endogenous Reporter Gene for MRI Cohen et al.
Neoplasia . Vol. 7, No. 2, 2005
Materials and Methods
Construction of C6-TET-EGFP-HA-Ferritin Cells
The murine ferritin H-chain cDNA (GenBank accession
no. NM-010239) with an HA (influenza hemagglutinin)
tag (HA-ferritin) and a Kozak sequence at the N-terminus
was generated by reverse transcription polymerase chain
reaction (RT-PCR). Retroviral gene delivery and expres-
sion system RevTet-Off-IN (Clontech, Palo Alto, CA) was
used to establish C6 cells expressing murine HA-ferritin
cDNA. HA-ferritin cDNA was cloned downstream of the
TET response element in the bidirectional pBI-EGFP
vector (Clontech) to form pBI-EGFP-HA-ferritin construct
(Figure 1). Packaging cells (PT67; Clontech) were trans-
fected with pRevTet-Off-IN, and the virus containing super-
natant was used to infect C6 cells. Stable C6 cells
expressing C6pRevTet-Off were selected with neomycin
(400 ml; Gibco-BRL, Life Technologies, Paisley, Scotland,
UK) and served as parental cells for cotransfection with
pBI-EGFP-HA-ferritin and pEIRES-Puro vector (20:1 molar
ratio) using FuGene 6 (Roche Diagnostics Corporation,
Mannheim, Germany). EGFP-expressing cells were se-
lected and expression of ferritin was monitored by Western
blot analysis. Stable cell populations were maintained in
DMEM containing the Tet system–approved and USDA-
approved FBS (DB Biosciences; Clontech, Palo Alto, CA)
supplemented with neomycin (400 mg/ml; Gibco-BRL/Life
Technologies) and puromycin (2.5 mg/ml; Sigma Chemical
Co., St. Louis, MO).
Neutral Red Staining of Viable Cells
Cells (2  104) were grown in a 96-well tissue culture
plate. After 24, 48, or 72 hours, the medium was discarded
and cells were stained (0.4% NR solution; 90 minutes, room
temperature), washed (1% formaldehyde, 1% CaCl), and
destained (50% ethanol, 1% acetic acid). Optical densities
were read at 595 nm [21].
Western Blot Analysis
Cells (3  105) were lysed in RIPA buffer [0jC; 20 mM
Tris, pH 7.4, 137 mM 10% glycerol, 0.5% (wt/vol) sodium
deoxycholate, 0.1% (wt/vol) sodium dodecyl sulfate (SDS),
1% Triton X-100, 2 mM EDTA; 200 ml of phenylmethylsul-
fonyl fluoride (PMSF; 1 mM), and protease inhibitor cocktail
(Sigma Chemical Co.)]. Equal amounts of protein (30 mg/
lane; Bradford method) were electrophoresed (15% SDS
polyacrylamide gel). Blocked membranes [2% BSA in
10 mM Tris-buffered saline, 0.05% Tween (TBST) 3 hours,
24jC] were incubated overnight (4jC) with either anti-HA
monoclonal antibody (HA.11, 1:1000; Covance, Inc., Berkeley,
CA), anti-GFP rabbit polyclonal antibody (1:5000; Abcam
Ltd., Cambridge Science Park, UK), or anti-actin polyclonal
antibody (1:1000; Sigma Chemical Co.). Membranes were
washed (3) with TBST and incubated with horseradish
peroxidase– labeled antibodies (1: 10,000; Zymed, Inc.,
San Francisco, CA).
MRI of Cell Suspension
Cells were suspended in 0.2 ml of agarose (1% in PBS) in
triplicates in a 96-well plate (2.5  105 cells/well). R1 and R2
relaxation rates were determined from spin-echo images at
4.7 T on a horizontal Bruker Biospec spectrometer (Bruker,
Karlsruhe, Germany) using a birdcage excitation coil (R1: 12
repetition times: 5000, 2000, 1000, 800, 700, 600, 500, 400,
300, 200, 100, and 50 milliseconds; TE 10 milliseconds; R2:
multiecho spin echo; TR 5000 milliseconds; eight echo
times: 10, 20, 30, 40, 50, 60, 70, and 80 milliseconds; two
averages; spectral width 50,000 Hz; matrix 128  128;
FOV 40  40 mm). A horizontal slice was selected using
orthogonal images, through the center of the cell suspension
of all wells (2 mm slice thickness at the center of 6 mm in
each well).
In Vivo MRI
Animal experiments were approved by the Weizmann
Institutional Animal Care and Use Committee. C6-TET-
EGFP-HA-ferritin cells were inoculated (subcutaneously;
106 cells/mouse) in the hind limb of CD1-nude mice (fe-
males, 6–10 weeks, 28–30 g). Ferritin overexpression was
suppressed by addition of TET to the drinking water [+Tet,
Tevacycline; 0.5 mg/ml and 3% sucrose, three times a week
starting 2 days before inoculation; Teva Pharmaceutical
Industries Ltd., Petah Tikva, Israel) or kept on (Tet; 3%
sucrose only). Three experiments were conducted (Tet, n =
12; +Tet, n = 15). Mice were imaged once in two experiments
and three times in the third experiment, when tumor diameter
was 4 to 6 mm.
MRI was acquired at 4.7 T using birdcage excitation coil
and actively decoupled 1.5-cm surface detection coil. Anes-
thesized mice (ketamine 75 mg/kg ip; Fort Dodge Animal
Health, Fort Dodge, IA; xylazine 3 mg/kg; Vitamed Ltd., Bat
Yam, Israel) were positioned with the tumor centered on the
surface coil. Coronal single-slice spin echo images were
selected on orthogonal images through the center of the
tumor (R1: five repetition times: 2000, 1000, 500, 200, and
100 milliseconds; TE 20 milliseconds; R2: multiecho spin
echo; TR 2000; four echo times: 20, 40, 60, and 80 milli-
seconds; two averages; spectral width 50,000 Hz;, FOV 20
20 mm; slice thickness 1 mm; matrix 128  128; in-plane
resolution 156 mm).
Analysis of MRI Data
Images were zero-filled to 256  256 so as to improve
spatial resolution by reducing partial volume artifacts [22].
Pixel-by-pixel single exponential fits of signal intensity (I) as a
function of TR or TE were done to generate longitudinal (R1)
and transverse (R2) relaxation maps, respectively (MATLAB
software; MathWorks, Inc. Hill Drive, Natick, MA):
Analysis of R1 : I ¼ I0ð1 eTRR1Þ
Analysis of R2 : I ¼ I0eTER2
Changes in relaxation rates were determined by selection
of a region of interest (for tumors or cell suspension) on the
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relaxation maps. Data are presented as mean ± SD of all
data points. P values reported were derived by unpaired,
two-tailed Student’s t test analysis.
Analysis of Gene Expression in Tumors
Total EGFP fluorescence was determined on formalde-
hyde-fixed whole tumors. Histologic tumor sections were
stained for HA-ferritin using fluorescein-labeled anti-HA an-
tibody [1:50, 1 hour; HA.11 monoclonal antibody (Covance,
Inc.) labeled with 5(6)-carboxyfluorescein, succinimidyl es-
ter; Molecular Probes, Inc., Eugene, OR], and for EGFP
using biotinylated goat anti-GFP antibody (1:100, 1 hour;
Abcam Ltd.) and ABC reagent (Vector Laboratories, Inc.
Burlingame, CA), visualized using DAB (Bio-Rad Laborato-
ries, Hercules, CA).
Determination of Intracellular Iron Content
Inductively coupled plasma atomic emission spectrome-
try [ICP-AES; Optima 3300, Perkin-Elmer, Boston, MA) was
used to determine iron content in C6 cells (106 per sample; +/
Tet; suspended in 50 ml of HNO3, 1 hour at 90jC and
diluted in 2 ml of DDW). In addition, intracellular iron was
stained with Prussian Blue (Sigma Chemical Co.).
Results
Overexpression of Ferritin H-Chain Leads to Elevated
Intracellular Iron Content
C6 rat glioma cells were transfected to express the murine
H-chain of ferritin under TET regulation. Two clones (cloned 1
and 2) were selected, in which significant overexpression of
both HA-tagged ferritin (HA-ferritin) and EGFP could be
effectively suppressed by TET (C6-TET-EGFP-HA-ferritin;
Figure 2). Thus, both EGFP and HA tag could be used for
independent validation of the expression of the transgene.
The cells were cultured in the absence or presence of TET,
and activation of expression of the transgene was initially
evaluated by fluorescence microscopy of EGFP (Figure 2a).
Western blot analysis of the HA-ferritin showed silencing of
overexpression on addition of TET, in a time-dependent man-
ner and in correlation with EGFPexpression level (Figure 2b).
The impact of ferritin overexpression on iron balance was
assessed by ICP-AES andPrussian Blue staining (Figure 2, c
and d). Staining cells with Prussian Blue showed a dose-
dependent suppression of iron uptake by TET (Figure 2c).
Intracellular iron uptake in response to overexpression of
ferritin, in the absence of TET, was confirmed by ICP-AES
analysis, showing a large rise of 27% and 66% in intracellular
iron content for clones 1 and 2, respectively (Figure 2d ).
Overexpression of Ferritin H-Chain Does Not Affect Cell
Proliferation
The impact of ferritin overexpression was evaluated by
checking cell proliferation and viability in vitro and tumor
progression in vivo as well as by histologic evaluation of
tumor specimens. Addition of TET followed by suppression of
ferritin overexpression did not cause any significant change
in the rate of cell proliferation up to 72 hours (Figure 3). In vivo
tumor progression appeared similar in mice supplied either
Figure 2. TET-regulated expression of EGFP-HA-ferritin in C6 rat glioma
cells augments iron uptake. (a) C6-TET-EGFP-HA-ferritin cells (clone 2) were
grown in culture plates in the presence or absence of TET (48 hours; 1 g/ml).
Confluent cell layers were examined for EGFP fluorescence (upper panel)
and in combination with bright field (lower panel). Scalebar = 50 m. (b) Time-
dependent expression of EGFP and HA-ferritin in C6 cells as a response to
TET switch (1 g/ml) was determined by Western blot analysis. -Actin was
used to normalize protein amounts. (c) Prussian Blue analysis of dose-
dependent TET-induced (48 hours) iron uptake into the cells. Staining intensity
was quantified by NIH image. (d) Quantification of intracellular iron content
by ICP-AES (1g/ml; 48 hours). Close and open bars represent clones 1 and 2,
respectively.
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with TET and sucrose in the drinking water or inmice supplied
only with sucrose (Figure 3). Hematoxylin–eosin–stained
histologic sections showed prevalence of multinucleated
giant tumor cells and, in the rim of some tumors, also infil-
tration of inflammatory cells, mainly lymphocytes and neu-
trophils. The tumors were highly vascular, showing a high
fraction of stroma endothelial cells. No detectable patho-
logic differences were associated with expression of the trans-
gene (Figure 4a).
TET-Regulated Overexpression of Ferritin H-Chain Is
Detectable in Tumor Samples
Subcutaneous C6-TET-EGFP-HA-ferritin tumors exam-
ined ex vivo by fluorescence microscopy and immunohisto-
chemistry staining of EGFP showed a significant difference
in expression of EGFP, consistent with the effect of the TET
switch (Figure 4, b and c). Fluorescence intensity was sup-
pressed by addition of TET to the drinking water (Figure 4c).
Staining of histologic sections with anti-GFP antibodies as
well as staining of the HA-tagged ferritin revealed that
administration of TET switched off the expression of the
transgene (Figure 4, b and d ). However, overexpression in
the absence of TET was not observed uniformly in all tumor
cells. Expression was particularly elevated in the multinucle-
ated giant tumor cells. HA tag or EGFP-stained cells occu-
pied less than 10% of the tumors not treated with TET. As
expected, infiltrating tumor stroma cells did not express the
transgene. The fraction of labeled cells was similar in tumors
of TET-treated mice, but the level of expression in these cells
was significantly reduced (Figure 4, b and d ).
Overexpression of Ferritin H-Chain Is Detectable by MRI
In Vitro
The sensitivity for the detection of expression of the
transgene by MRI depends on the density of the expressing
cells, the level of expression, and the corresponding changes
in iron content. Although the significant change in expression
level and the robust change in iron content were encourag-
ing, the very low percentage of cells showing a high expres-
sion in tumors provided a challenge for detection by MRI. We
thus tested the ability to detect changes in MRI relaxation
rates in cell suspensions using a low density of cells (2.5 
105 cells suspended in 0.2 ml of agarose). This cell density is
40-fold lower than previously reported for in vitro MR detec-
tion of TET-regulated expression of tyrosinase [11].
In vitro MRI analysis of longitudinal (R1) and transverse
(R2) relaxation rates of cell suspensions showed highly
significant changes with administration of TET (Figure 5).
The enhanced relaxation rate in the absence of TET was
consistent with induced expression of the transgene and with
Figure 3. Expression of ferritin does not affect the growth of C6-TET-EGFP-HA-ferritin cells in vitro or in vivo. (a) In vitro growth rate of C6-TET-EGFP-HA-ferritin
cells cultured in the absence or presence of TET (1 g/ml; up to 72 hours) calculated using neutral red assay (n = 3–5; mean ± SD). (b) In vivo growth rate of C6-
TET-EGFP-HA-ferritin tumors measured from MR images. C6-TET-EGFP-HA-ferritin cells (clone 1) were inoculated in the hind limb of nude mice and the mice
were supplied with TET and sucrose (n = 7; or sucrose only, n = 4) in drinking water for 4 weeks (mean ± SD).
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the measured increase in intracellular iron (Figure 2). Thus,
both clones revealed that R1 and R2 were significantly
elevated in the absence of TET, and were lower when cells
were treated with TET, thereby suppressing overexpression
of the transgene (two-tailed unpaired, P V .0006). These
results demonstrate the high sensitivity of MRI relaxation
rates and ferritin as a reporter, which can be utilized for
the detection of changes in gene expression even at very
low cell density.
In Vivo MRI Detection of TET-Induced Expression of Ferritin
H-Chain in Tumors
In order to determine the ability to detect changes in
relaxivity associated with induced gene expression in vivo,
C6-TET-EGFP-HA-ferritin cells were inoculated subcutane-
ously in CD-1 nude mice. TET was supplied in the drinking
water in order to suppress the overexpression of EGFP and
ferritin in the tumor (+Tet), whereas the transgene was
overexpressed in the absence of TET (Tet). In three
different experiments, both R1 and R2 relaxation rates were
elevated in the ferritin-overexpressing tumors (Tet). An
example of one study is presented in Figure 6 for four
transgene-expressing (Tet) mice and seven mice in which
transgene expression was suppressed (+Tet; Figure 6). R1
was significantly elevated at early stages of tumor growth,
whereas R2 was significantly increased by switching on the
expression of the transgene throughout the course of tumor
growth (two-tailed unpaired, P < .05; Figure 6).
Discussion
A number of MRI reporters of gene expression were pub-
lished so far, all of which were dependent on exogenous
contrast agents for generation of detectable contrast
changes [1–7,10,11]. In the study reported here, the H-chain
of ferritin was applied as the first endogenous intracellular
reporter of gene expression that is detectable by MRI, both
in vitro (in cell suspensions) and in vivo (in solid tumors). In
both cases, no administration of exogenous contrast agents
was required.
Independent validation of MRI reporters is important due
to the indirect detection of contrast changes in MRI that
depend on changes in the relaxation rates of the abundant
water signal. To gain such a validation, expression of both
EGFP and HA-tagged ferritin was placed under a tight TET
switchable promoter using a bidirectionally expression vec-
tor. Thus, independent detection and cross-validation of
changes in the expression of the reporter transgene were
provided by measurements of fluorescence and MR relaxa-
tion rates in genetically identical cells or tumors. Sensitivity for
detection of ferritin was high; thus, TET withdrawal and ac-
tivation of ferritin expression resulted in significant changes
in relaxation rates even for very low densities of cells.
The use of ferritin as a reporter for MRI is based on the
hypothesis that sensitivity for the detection of ferritin over-
expression by MRI would be enhanced by redistribution of
intracellular iron as well as by a physiological response
leading to net intracellular iron uptake. The bases for this
Figure 4. TET-regulated overexpression of EGFP-HA-ferritin in tumors. C6-
TET-EGFP-HA-ferritin cells (clone 1) were inoculated in the hind limb of nude
mice. TET and sucrose (or sucrose only) were supplied in drinking water and
the tumors were retrieved for histology at the end of 4 weeks. (a) Histologic
sections stained with hematoxylin–eosin. Multinucleated giant tumor cells
(arrowheads) and infiltrating inflammatory cells at the tumor rim (arrows) are
indicated. (b) Histologic sections stained with anti-GFP polyclonal antibody
(brown), counterstained with hematoxylin. (c) Expression of EGFP in
subcutaneous tumors and skin whole mounts visualized by fluorescent
microscopy. (d) Histologic sections stained with fluorescent anti-HA antibody
(green) and nuclear stain (Hoechst, Molecular Probes, Inc., Eugene, OR;
blue). Scalebar = 50 m (a and b), 1 mm (c), and 200 m (d).
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work are previous studies that demonstrated the ferroxida-
tion reaction catalyzed by the ferritin H-chain [16,23]; the
anomalies of ferritin relaxivity, which is particularly high for
ferritin at low iron loading [19,24–26]; and the demonstration
of redistribution of iron between ferritin molecules [27]. In
addition to that, induction of iron deficiency mechanisms in
cells exposed to overexpression of H-ferritin was reported,
including induced expression of transferrin receptor and
increased iron uptake [16].
The anomalous relaxivity of ferritin has been well charac-
terized [19,24–26]. Although ferritin can carry a core of a few
thousand iron atoms, detailed studies by Vymazal et al.
[25,26] revealed maximal relaxivity at a very low loading
factor of 13 ± 14 iron atoms per molecule These results imply
that induced expression of apoferritin could result in alter-
ations of R1 and R2 relaxation rates and thus lead to changes
in MRI contrast, even in the absence of a change in total
intracellular iron content, provided that redistribution of iron
between ferritin complexes is possible. Indeed, migration of
iron atoms that are not incorporated into mature ferrihydrite
particles between ferritin molecules was demonstrated by
Mossbauer spectroscopy [27]. The higher sensitivity of R2
relative to R1 for the detection of ferritin expression, as
reported here, and the corresponding larger variability in R1
are in accord with the mechanism of relaxivity and previous
studies of ferritin suspension [28].
However, the effects of overexpression of ferritin on MR
contrast are not limited to the redistribution of iron. In fact, as
shown here, overexpression of ferritin resulted in a signifi-
cant increase in net intracellular iron content, which was
detected by Prussian Blue staining and ICP-AES. The com-
pensation for ferritin expression by augmented iron uptake is
consistent with previous reports that overexpression of the
ferritin H-chain induced expression of transferrin receptor
and increased iron uptake [16].
The nonuniform relaxation rates in the tumor are consis-
tent with the variable degree of transgene expression as
seen by immunohistochemistry. It should be noted that
Figure 5. In vitro MRI detection of switchable ferritin expression in C6 rat glioma cells. (a and b) R1 and R2 relaxation rate maps of C6-TET-EGFP-HA-ferritin cell
samples suspended in agarose and placed in a 96-well plate. Two clones are shown incubated with and without TET (5 days; 1 g/ml). (c and d) Relaxation rates
derived from the R1 and R2 maps (mean ± SD; n = 3, P values: two-tailed unpaired t-test).
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relaxation rates include contribution from other factors, in
addition to ferritin. Selection of ferritin contribution could
perhaps be facilitated by its unique field dependence [29].
One of the requirements from a reporter is that it will have
minimal impact on the studied process. Due to the high
reactivity of iron, particularly in oxygenated environment,
homeostasis of intracellular iron is fine-tuned by a panel of
iron-regulated genes whose expression and stability are
regulated at the mRNA level through specific iron response
elements [30–32]. Ferritin expression is typically induced in
the presence of elevated levels of iron; its expression is
suppressed, whereas expression of transferrin receptor is
induced in iron deficiency. The observed increase in iron
content suggested that cells were able to compensate for
iron chelation into ferritin by inducing iron uptake. It is
important to note that overexpression of ferritin, whose role
is to detoxify free iron by its sequestration, is expected to
produce less undesirable physiological effects than over-
expression of transferrin receptor, a previously publishedMR
reporter that could elevate the level of reactive soluble iron in
cells [2]. Overexpression of ferritin in an iron-independent
manner could result in iron deficiency, and accordingly,
affect cell proliferation; however, as shown here, overex-
pression of H-ferritin did not alter growth rate in vitro or
in vivo. These results are in line with previous studies of
MEL cells [33] but in contrast to studies of HeLa cells [16],
suggesting variability among cells in sensitivity to changes
in iron homeostasis.
The high sensitivity for detection of ferritin by MRI is
manifested by the fact that the number of cells that we were
able to detect in vitro was 40-fold lower than that reported for
TET-regulated expression of tyrosinase [11]. Furthermore, it
Figure 6. In vivo MRI detection of switchable ferritin expression in C6 tumors. MRI of ferritin-expressing tumors at different times after inoculation of C6-TET-
EGFP-HA-ferritin tumor cells (clone 1) in the hind limb of nude mice. TET and sucrose (or sucrose only) were supplied in drinking water, starting 2 days before
inoculation. (a) R1 and R2 maps of tumor regions overlaid on the MR images are shown for two representative mice from each group. (b) R1 and R2 values (mean ±
SD) at the tumor region in the presence (ferritin off; n = 7) or absence (ferritin on; n = 4) of TET in drinking water. All four Tet mice were imaged three times each
(on days 14, 19, and 28 after tumor inoculation). All seven +Tet mice were imaged on the first (day 14) and second (day 19) MRI sessions, and five of these mice
were scanned also on the third (day 28) session. *P < .05: two-tailed unpaired t-test. Scalebar = 2.5 mm.
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should be noted that tyrosinase contrast was detectable only
after supplementation of exogenously administered iron,
whereas ferritin contrast reported here was endogenous
and was achieved with no exogenously administered con-
trast agents. Thus, despite the low fraction of transgene-
expressing cells within subcutaneous tumors, the change in
relaxation rate was significant and was detectable through-
out tumor progression. Combination of ferritin expression
with HA-tag and EGFP as reported here provides a means
for independent validation and complementary analysis by
optical imaging.
In summary, the results presented here demonstrate that
the use of ferritin as a reporter for in vivo mapping of gene
expression by MRI is feasible. The first demonstration of this
approach, as reported here for tumors, may aid the tracking
of tumor cell migration. However, this approach could open
many additional exciting possibilities for studying the activa-
tion of genes during development and in disease models, as
well as for specific labeling of cells for tracking cell recruit-
ment and migration. The use of endogenous reporter gene
as developed here would be particularly beneficial in those
cases where administration of contrast material is compro-
mised by barriers, including embryonic development and the
central nervous system.
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